文献速递血栓与止血

无诱因静脉血栓栓塞症患者血浆P-选择素糖蛋白配体-1阳性微囊泡水平升高

Elevated plasma levels of P-selectin glycoprotein ligand-1-positive microvesicles in patients with unprovoked venous thromboembolism.
PubMed 文献 · J Thromb Haemost · 2018-05-31

一项基于人群的病例对照研究纳入20例无诱因静脉血栓栓塞症(VTE)患者和20例年龄性别匹配的健康对照,采用流式细胞术、电镜和共聚焦显微镜检测血浆PSGL-1+微囊泡水平、细胞来源及形态特征。结果显示PSGL-1+微囊泡水平与VTE风险相关,校正年龄和性别后每增加一个标准差的比值比为3.11(95%CI 1.41-6.88),进一步校正体重指数后为2.88(95%CI 1.29-6.41)。微囊泡主要来源于单核细胞和内皮细胞。

要点

  • 无诱因VTE患者血浆PSGL-1+微囊泡水平高于健康对照。
  • PSGL-1+微囊泡每增加一个标准差,VTE风险比值比为3.11(95%CI 1.41-6.88)。
  • PSGL-1+微囊泡主要来源于单核细胞和内皮细胞,直径50-300 nm。

核心结论

  • 血浆PSGL-1+微囊泡水平升高与无诱因VTE风险相关。
  • 作者指出需要大型基于人群的前瞻性研究来验证这些发现。

研究设计与样本

  • 基于人群的病例对照研究,纳入20例有无诱因VTE病史的患者和20例从普通人群招募的年龄性别匹配健康对照。
  • 采用流式细胞术、电子显微镜和共聚焦显微镜评估PSGL-1+微囊泡的血浆水平、细胞来源和形态特征。

主要发现

  • PSGL-1+微囊泡血浆水平与VTE风险增加相关,校正年龄和性别后每增加一个标准差的比值比为3.11(95%CI 1.41-6.88)。
  • 进一步校正体重指数后,每增加一个标准差的比值比为2.88(95%CI 1.29-6.41)。
  • 通过流式细胞术双染亲本细胞标志物和透射电镜确定PSGL-1+微囊泡主要来源于单核细胞和内皮细胞。
  • 扫描电镜显示PSGL-1标记的血浆来源微囊泡主要为球形囊泡,直径在50至300 nm之间变化。

局限性

  • 作者指出需要大型基于人群的前瞻性研究来验证这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Essentials PSGL-1+ microvesicles (MVs) may be important in venous thromboembolism (VTE). We measured plasma levels and parental origin of PSGL-1+ MVs in patients with unprovoked VTE. VTE patients had higher plasma levels of PSGL-1+ MVs than healthy controls. The PSGL-1+ MVs originated mainly from monocytes and endothelial cells. SUMMARY: Background Microvesicles (MVs) express antigens from their parental cells and have a highly procoagulant surface. Animal studies suggest that P-selectin glycoprotein ligand-1-positive (PSGL-1+ ) MVs play a role in the pathogenesis of venous thromboembolism (VTE). Objective The aim of this study was to determine plasma levels, the cellular origin and the morphological characteristics of PSGL-1+ MVs in patients with unprovoked VTE. Methods We conducted a population-based case-control study in 20 patients with a history of unprovoked VTE and 20 age- and sex-matched healthy controls recruited from the general population. Plasma levels, the cellular origin and the morphological characteristics of PSGL-1+ MVs were evaluated using flow cytometry, electron microscopy and confocal microscopy. Results Plasma levels of PSGL-1+ MVs were associated with increased risk of VTE. The odds ratio per one standard deviation increase in PSGL-1+ MVs was 3.11 (95% confidence interval [CI], 1.41-6.88) after adjustment for age and sex, and 2.88 (95% CI, 1.29-6.41) after further adjustment for body mass index. The PSGL-1+ MVs originated mainly from monocytes and endothelial cells determined by double staining with markers of parental cells using flow cytometry and transmission electron microscopy. Scanning electron microscopy of PSGL-1-labeled plasma-derived MVs displayed dominantly spherical vesicles that varied between 50 and 300 nm in diameter. Conclusions Increased plasma levels of PSGL-1+ MVs are associated with the risk of unprovoked VTE. Large population-based prospective studies are required to validate our findings.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Jamaly S, Basavaraj MG, Starikova I, et al. Elevated plasma levels of P-selectin glycoprotein ligand-1-positive microvesicles in patients with unprovoked venous thromboembolism. J Thromb Haemost. 2018. PMID: 29851269. doi:10.1111/jth.14162

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。